Atara Biotherapeutics Inc...

NASDAQ: ATRA · Real-Time Price · USD
12.25
0.53 (4.52%)
At close: Aug 15, 2025, 3:08 PM

Atara Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
128.94M 8.57M 63.57M 20.34M
Cost of Revenue
21.01M 8.89M 14.57M 11.38M
Gross Profit
107.93M -313K 49.01M 8.96M
Operating Income
-83.44M -276.01M -280.51M -340.46M
Interest Income
2.11M 5.43M 3.06M 367K
Pretax Income
-85.42M -276.11M -228.29M -340.1M
Net Income
-85.4M -276.13M -2.28B -3.4B
Selling & General & Admin
39.89M 49.8M 71.55M 78.8M
Research & Development
151.48M 224.78M 272.53M 282M
Other Expenses
n/a n/a -700K n/a
Operating Expenses
191.37M 275.69M 344.09M 360.8M
Interest Expense
4.62M 5.29M 373K n/a
Selling & Marketing Expenses
n/a -1.11M n/a n/a
Cost & Expenses
212.38M 284.58M 344.09M 360.8M
Income Tax Expense
-12K 15K 12K 46K
Shares Outstanding (Basic)
7.49M 4.24M 4.08M 3.75M
Shares Outstanding (Diluted)
7.49M 4.24M 4.08M 3.75M
EPS (Basic)
-11.41 -65.18 -55.96 -90.78
EPS (Diluted)
-11.41 -65.18 -55.96 -90.78
EBITDA
-75.75M -266M -213.72M -331.12M
EBIT
-80.8M -270.83M -228.29M -340.46M
Depreciation & Amortization
5.05M 4.83M 14.57M 11.38M